The incidence and prevalence of Type 2 diabetes (T2D) has been increasing globally since the late 1990s, particularly in children and adolescents. Development of T2D subsequently increases an individual’s risk of developing cardiovascular and renal disease, further adding to the global disease burden. Optimisation of T2D diagnosis and management approaches is required to reduce cardiorenal risk and improve patient outcomes.